Our partner is dedicated to developing targeted therapies using protein degradation technology. Their approach aims to address a wide range of diseases, including cancer, by selectively eliminating disease-causing proteins, ultimately improving patient outcomes through precision medicine.

This critical hire drove the strategy and execution of program timelines at a clinical-stage biopharmaceutical company focused on targeted protein degradation therapeutics. Leading a cross-functional team across clinical operations, regulatory affairs, and other key departments, they ensured successful delivery against program goals. The role offered an exciting opportunity to contribute to cutting-edge advancements in the protein degradation field.